Clinical trial
Modafinil in Multiple Sclerosis
NCT00142402 · Kessler Foundation, Other · Completed
Key facts
| NCT number | NCT00142402 |
|---|---|
| Title | Modafinil in Multiple Sclerosis |
| Official title | Modafinil for Improving New Learning and Memory in Multiple Sclerosis |
| Lead sponsor | Kessler Foundation, Other |
| Collaborators | National Multiple Sclerosis Society |
| Status | Completed |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Modafinil |
| Enrollment | 20 |
| Start date | Jun 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 2, 2005 |
| Last update posted | Sep 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: